Laura Leung, PhD

Principal Scientist
Avidity Biosciences
San Diego, California, United States

Presentation(s):

• Hitching a Ride to Transduce Barriers: Nonclinical Safety Considerations for Developing Transcriptome Modulating Therapies (S08)

  Tuesday, November 19, 2024
  9:00 AM – 12:00 PM CT

• Nonclinical Safety Assessment of Antibody-Oligo Conjugates from IND-enabling through Late-Stage Clinical Trials (S08-4)

  Tuesday, November 19, 2024
  10:45 AM – 11:15 AM CT